Matching slides 1,583
Current window 1,141-1,170
Pages 53
Rows per page 30
Loop: 53 Jobs To Be Doneclear collectionreset all

Loop

1,141-1,170 of 1,583

filter-aware
38
The slide uses a process-flow icon at the top to indicate the 'Hit ID' stage of a drug discovery pipeline.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
39
The slide uses a Venn-like overlapping pill shape to show how specific data modalities (Phenomics, Transcriptomics, etc.) feed into different stages of the drug discovery process.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
40
The slide illustrates a drug discovery pipeline workflow.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
41
The slide uses a funnel-like progression visual to show how different technologies (Phenomics, Transcriptomics, InVivomics) integrate into the drug discovery process.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
42
The slide uses a before-after framing to contrast manual/mechanical observation with automated digital tracking.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
43
The slide uses a before-after framing to contrast traditional manual rotarod assays with high-throughput digital phenotyping.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
44
The slide uses a comparison frame to highlight speed advantages.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
45
The slide uses a layered circular process flow diagram to represent the progression of drug discovery stages.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
46
The DMTA cycle is represented as a circular process flow.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
47
Includes a process flow diagram at the top and specific performance metrics for chemical algorithms.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
48
The slide features a technical diagram of a DeBERTa-based architecture for chemistry and biology pre-training.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
49
The slide features a process flow diagram at the top right and a photo of the Biosero robotic system.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
50
Includes a process flow icon at the top right indicating the stage of the drug discovery pipeline.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
51
The diagram uses a layered stack to represent data integration, connected by nodes.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
52
Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slidesRecursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
53
The heatmap shows a diagonal of high correlation (red) and various clusters of gene interactions.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
54
The heatmap likely represents a correlation matrix or gene-gene interaction map. The slide uses a two-column layout to categorize capabilities.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
55
The image on the right is a network graph visualization, likely representing protein-protein interactions or molecular pathways.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
56
The slide uses a before-after framing to contrast the current market reality with the desired therapeutic outcome.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
57
The slide outlines a drug discovery workflow from target identification to preclinical validation.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
58
The slide uses a 'problem-solution' structure, contrasting the high unmet need in cancer patients (left) with the efficacy of the REC-0648918 compound in mouse models (right).Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
59
The slide uses a 'problem-solution' structure, contrasting market statistics with experimental dot plots.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
60
The slide uses a problem-solution structure, contrasting market statistics with experimental cytokine data.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
61
The slide uses a problem-solution framing: the left side establishes the market problem (low efficacy/high toxicity), and the right side presents pre-clinical data as the solution.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
62
The slide uses a process-oriented layout to explain how medicinal chemistry efforts are informed by assay data.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
63
The slide highlights a specific subset of data (Compound 2A/2B) where phenomics shows a dramatic improvement, suggesting a redirection of chemistry efforts.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
64
The slide contrasts standard dose-response curves (univariate) with a phenotypic similarity matrix (heatmap) to highlight the value of phenomics in drug discovery.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
65
The slide uses a heatmap to visualize phenotypic similarity/clustering, highlighting the 'Target Phenotype' vs 'Compound 2A' (CDK9).Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
66
The slide uses heatmaps to visualize gene-gene and compound-phenotype correlations, highlighting the platform's ability to identify specific biological relationships.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
67
The image on the right is a network graph, likely representing protein-protein interactions or a biological pathway map.Recursion Pharmaceuticals | Investor Day Presentation Deck | 143 slides · Recursion Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit